Drug company funded research in the New England Journal of Medicine: this feels like a conflict of interest
Today I thought I'd read the New England Journal of Medicine (NEJM) and learn something deeply meaningful. I usually love the New England Journal (Wikipedia says it is " among the most prestigious peer-reviewed medical journals and the oldest continuously published one ") because I feel like it has such a strong history of academic excellence that whatever they print will have value. This is probably not true. The New England Journal In 2009, Marcia Angell MD, a senior lecturer at Harvard University and the former Editor in Chief of the NEJM wrote an article entitled "Drug Companies and Doctors, a Tale of Corruption" in the New York Review about the way drug companies skew research to encourage increasing and inappropriate use of medications. It was based on what she had seen published in the New England Journal and others. This might have been a hint that there was something amiss in the contents of my favorite professional publication. In 2012, the W...